Novavax, Inc.

Novavax, Inc.

Novavax, Inc.

Overview
Date Founded

1987

Headquarters

20 Firstfield Road,Gaithersburg, MD 20878

Type of Company

Public

Employees (Worldwide)

791

Industries

Biotechnology

Company Description

Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Contact Data
Trying to get in touch with decision makers at Novavax, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Vice President, Chief Financial Officer & Treasurer

Senior Vice President & Chief Information Officer

Executive Vice President, Chief Legal Officer & Corporate Secretary

Executive Vice President, Chief Medical Officer

Executive Vice President, Nanoflu General Manager

President, Research & Development

Executive Vice President, Chief Commercial Officer, Chief Business Officer & Interim Chief Financial Officer

Senior Vice President, Discovery & Pre-Clinical Research, Chief Scientist

Senior Vice President, Quality Operations

Board of Directors

Director at CannaRoyalty Corp.

Former President, Chief Executive Officer & Director at International AIDS Vaccine Initiative

Former Chief Executive Officer & Director at NGAS Resources, Inc.

Former President & Chief Executive Officer at Jamcor Pharmaceuticals, Inc.

Chairman at Zyngenia, Inc.

Co-Founder at GlycoMimetics, Inc.

Director at EQL Pharma AB

Former Senior Vice President-Corporate Development at Genzyme Corp.

President's Advisory Council on HIV/AIDS at United States Department of Health & Human Services

Paths to Novavax, Inc.
Potential Connections via
Relationship Science
You
Novavax, Inc.
Owners & Shareholders
Details Hidden

RA Capital Management, LLC (“RA Capital”) is a crossover fund manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with minimal capital concerns from inception through commercialization.

Details Hidden

Carmignac is an active manager which employs a long-term investment strategy. The firm invests predominantly in equity with no market-cap restrictions and favors sectors such as raw materials, energy and precious and non-precious metals. Investment themes include consumption in emerging regions, China, Brazil and South Korea. They also invest in US large-cap companies. Carmignac employs a flexible, top-down sector allocation process and emphasizes liquidity. Emerging markets account for a sizeable proportion of their portfolios.

Details Hidden

Rock Springs’ funds aims to generate capital appreciation through investments in a combination of public and private securities of companies in healthcare and healthcare-related industries. The funds focus mostly on public equities, utilizing a long-term, research-intensive approach to investing in healthcare and healthcare-related industries, with a particular emphasis on those companies and/or products that Rock Springs believes serve critical unmet needs.

Recent Transactions
Details Hidden

Novavax, Inc. issued . USD Common Stock

Details Hidden

Novavax, Inc. issued USD Common Stock

Details Hidden

Novavax, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Escrow Agent

Advised onNovavax, Inc. issued USD Common Stock

Legal Advisor

Advised onNovavax, Inc. issued USD Common Stock

Underwriter

Advised onNovavax, Inc. issued USD Common Stock

Legal Advisor

Advised onNovavax, Inc. issued USD Common Stock

Underwriter

Advised onNovavax, Inc. issued USD Common Stock

Legal Advisor

Advised onNovavax, Inc. issued USD Common Stock

Advisors & Consultants
Real Estate Agent

Managing Director, Brokerage at Jones Lang LaSalle

Legal Advisor

Partner at Ropes & Gray LLP

Consultant

Chief Operating Officer & Chief Financial Officer at Ribometrix, Inc.

Clients

Government of the United Kingdom is the central government of the United Kingdom of Great Britain and Northern Ireland.The government is led by the Prime Minister, who selects all the remaining ministers. The prime minister and the other most senior ministers belong to the supreme decision-making committee, known as the Cabinet.

The federal government of Canada is the body responsible for the federal administration of Canada. In Canadian English, the term can mean either the collective set of institutions (the legislative, executive, and judicial branches) or specifically the Queen-in-Council (the executive, also called Her Majesty's Government.

The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington.

Key Stats and Financials As of 2020
Market Capitalization
$12.7B
Total Enterprise Value
$6.09B
Earnings Per Share
$-7.27
Revenue
$476M
EBITDAMargin
-86.03%
Enterprise Value / Sales
12.82x
TEVNet Income
-14.57x
Debt TEV
0.08x
EBITDA
$-409M
Total Equity
$627M
Total Debt
$482M
Net Profit
$-418M
Three Year Compounded Annual Growth Rate Of Revenue
148.01%
Non-Profit Donations & Grants
Non-Profit Donations & Grants Received
Suppliers
Cadila Pharmaceuticals Ltd. Biotechnology | Ahmedabad, India

Cadila Pharmaceuticals Ltd. manufactures and distributes pharmaceutical products. The company is involved in manufacturing pharmaceutical products, new drug discovery, novel drug delivery, analytical research, biosynthesis and genetic engineering. It also manufactures cardiovascular, gastrointestinal, anti inflammatory, antibiotics, vaccines, anti-diabetic and vitamin drugs. The company was founded in 1951 by Indravadan Ambalal Modi and is headquartered in Ahmedabad, India.

Brooks Automation, Inc. Computer Software | Chemsford, MA

Brooks is a leading worldwide provider of automation, vacuum, and instrumentation solutions for multiple markets including semiconductor manufacturing, life sciences, and clean energy. Our technologies, engineering competencies, and breadth of global services provide customers speed to market, high uptime, and rapid response, which equate to superior value in their mission-critical environments. Since 1978, Brooks has been a leading partner to the global semiconductor manufacturing market. Through product development initiatives and strategic acquisition, we have expanded our reach to meet the needs of customers in the life sciences industry, analytical and research fields, and clean energy markets. When optimal productivity and high availability are factors for success, customers across the globe turn to Brooks. Brooks is a public company listed on the NASDAQ stock exchange under the symbol BRKS

Catalent, Inc. Other Business & Consulting Services | Somerset, NJ

Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment offers formulation, development, and manufacturing services for soft capsules or softgels, as well as large-scale production of oral solid dose forms for pharmaceutical and consumer health markets, and supporting ancillary services. The Biologics segment develops and produces biologic cell-line, cell therapy, and viral vector gene therapy; formulation for parenteral dose forms, which include prefilled syringes, vials, and cartridges; and analytical development and testing services for large molecules. The Oral and Speciality Delivery segment consists of advanced formulation of a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment involves packaging, storage, distribution, and inventory management for drugs and biologics in clinical trials. The company was founded in 1933 and is headquartered in Somerset, NJ.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

AstraZeneca Plc Pharmaceuticals - Cambridge, United Kingdom

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Novavax, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Novavax, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Novavax, Inc..